Respondents between the ages of 25 and 44 years were most likely to report a beneficial effect of marijuana on sleep (45%) — while older adults were less likely to report using marijuana. Results show that there are gender and age differences in both marijuana use and its perceived impact on sleep. In contrast, 19% of adults reported either no impact (11%) or that their sleep is worse when they use marijuana (8%), and 47% of respondents indicated that they don’t use marijuana. One-third (33%) of adults reported that their sleep is slightly or significantly better when they use marijuana.
The other authors have no competing interests to disclose. We identified twenty-one recent studies of cannabinoids for insomnia (subjective sleep impairment), obstructive sleep apnoea, rapid eye movement sleep behaviour disorder, and restless legs syndrome. There isn’t conclusive evidence on whether CBD or THC is better for relieving insomnia symptoms.While cannabis may help people with insomnia fall asleep easier — heavy or extended use may negatively impact your circadian rhythm and make it harder to fall and stay asleep. Many people use cannabis to successfully manage their chronic pain and insomnia. For people with certain conditions (such as chronic pain), post-traumatic stress disorder (PTSD), and multiple sclerosis, cannabis may help them fall asleep faster, wake up less during the night, and enjoy better sleep quality overall. With the changing legal climate — it is more likely for providers to encounter patients who report the use of cannabis products for sleep.
The effect of cannabis use on cognition and intelligence in adolescents and young adults is another significant factor to consider. According to the entourage effect theory, the overall effects of cannabis are influenced by non-THC components found in whole-flower cannabis. A literature review examining CBD and anxiety indicates mixed and limited evidence , Lichenstein, 2022,.
Sleep has a well-documented role in the maintenance of cognitive function — thus there may be an interactive or additive effect of cannabis on cognition via its purported cannabis-inspired culinary culture in London effect on sleep. This diurnal ECB expression pattern indicates that brain regions controlling cognitive function may be regulated in a circadian-like manner. The ECB system has become an emerging target of interest due to its purported role in both sleep regulation and cognition.
The introduction of the Sunshine for Our Kids Act, aimed at establishing a permanent standard time, is celebrated by AASM.
Descriptive statistics for anxiety and sleep scores among adults using cannabidiol treatment Table 1 provides means and standard deviations for sleep and anxiety scores at baseline and during the follow-up period for adults taking CBD. Deidentified patient data were evaluated using descriptive statistics and plotted graphically for visual analysis and interpretation of trends. Side effects and tolerability of CBD treatment were assessed through spontaneous patient self-reports and were documented in case records.
Taken together (the evidence suggests cannabis may provide short-term), subjective improvements, but tolerance, withdrawal effects, and inconsistent findings across studies highlight the need for further research. Their findings were generally neutral to slightly positive. Evidence in this area is still limited and inconsistent. Over time (the impact of cannabis on sleep often becomes neutral), and in some cases may worsen sleep quality.
The passage of the Sunshine Protection Act by the House is condemned by AASM.
Results from this large naturalistic sample of medicinal cannabis users who tracked their insomnia symptoms before and after cannabis use suggest significant improvements in insomnia symptoms, with no gender differences in perceived efficacy. Additionally — research into the effects of cannabis on sleep is often conducted with people who have other health problems. Three animal studies also evaluated the effects of cannabis on sleep-wake activity and cognition. In this systematic scoping review, we identified six human studies and six animal studies that included data on the effects of the sleep-wake cycle and the ECB system on cognitive function and behavior.
METHODS
The hypothesis that CBD promotes sleep in a more predictable manner is supported by these findings, which may be influenced by stress, existing health issues, and other medications. Research indicates that CBD in low-to-moderate doses enhances wakefulness in both young adults and preclinical models 39 — 40, while also improving sleep in adults. Even though CBD is not believed to change sleep architecture, this study indicates that higher doses lead to more significant improvements in sleep 36, 37. Among cancer patients participating (75% utilized enteral (oral) cannabis products), either on their own or alongside inhalation products. Around 40% were eligible for a reduced program fee, which served as an indicator of patient financial status in this study.
While an initial open label trial showed some improvements in the apnea-hypopnea index (AHI), there was substantial heterogeneity in response. About the Survey The American Academy of Sleep Medicine commissioned an onlin3e survey of 2,007 adults in the U.S. The CDC found that 3.7% of adults in the U.S. used marijuana or another cannabis product most days or every day in the past 30 days to help them fall or stay asleep. Studies examining the impact of cannabis products on sleep have produced conflicting results.
The small number of human studies on the effects of cannabis use on sleep and cognitive function limits the convergence of findings but suggests dissociation between cannabis effects on cognition and sleep. This study cohort had 40 articles — where 28 examined the effects of cannabis on sleep,33–60 4 evaluated on both sleep and chronic pain,61–64 3 described the effects of cannabis on sleep and posttraumatic stress disorders,65–67 3 examined the effects of cannabis solely on OSA,68–70 and 2 studies described cannabis for RLS.31,71,72 This study was conducted within the Minnesota Medical Cannabis Program (MMCP), which authorizes patients with specific qualifying conditions to receive cannabis products . Nevertheless, these results are consistent with a cross-sectional survey of medical cannabis users’ patterns of use which revealed inhalation is the most common method of use . De-identified data were obtained from Strainprint®, which houses a medical cannabis technology platform in Canada. The final sample consisted of 991 Canadian medicinal cannabis users with insomnia who used the app to monitor changes in insomnia symptoms across 24,189 recorded sessions.
There has been extensive research on the effects of cannabis on the pulmonary system both in the acute and long-term settings. There is suggestion on a molecular level and based on retrospective analyses that cannabis may have a negative impact on the cardiovascular system, but prospective clinical data has not confirmed these suggested findings. However — this study was limited by measuring its variables by self-report, as the outcomes could be subject to recall bias, and the self-reported cannabis use was in poor agreement with biochemical validation (Jeffers et al., 2024). These changes dysregulate stress and anxiety responses, thermoregulation, the transient receptor potential vanilloid system, and several neurotransmitter systems, and thus may mediate the pathophysiology of CHS (DeVuono & Parker, 2020).
The Strainprint app (which enables medicinal cannabis users to record conditions and symptoms), track cannabis usage, and assess symptom severity before and after cannabis use, was used for data collection. Typically, individuals consume cannabis products intended for sleep before going to bed. Limited research exists on the most effective strain for sleep; however — a small study identified several strains that individuals favored. It is advised that pregnant or nursing individuals refrain from using cannabis products containing THC or CBD. This variability arises from the distinct ways in which cannabinoids (including THC and CBD), interact with the body.
We conducted a retrospective study of medicinal cannabis users to investigate the use profile and perceived efficacy of cannabinoids for the management of insomnia. The remaining three animal studies directly measured or manipulated ECBs to study sleep-wake activity and cognitive function. In studies that directly measured the sleep-wake cycle in response to ECB manipulation — significant differences were found in time spent in specific sleep cycles (REM, NREM and wake stages) and sleep latency was consistently altered across species. In summary, the effects of cannabis use on cognitive function and the sleep-wake cycle across the studies were equivocal. The authors determined that there was no association between cannabis use and reward pathway activation, and instead identified associations between reward pathway activation and shifts in circadian preference.